845 related articles for article (PubMed ID: 31037148)
1. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.
Feng X; Sureda A; Jafari S; Memariani Z; Tewari D; Annunziata G; Barrea L; Hassan STS; Šmejkal K; Malaník M; Sychrová A; Barreca D; Ziberna L; Mahomoodally MF; Zengin G; Xu S; Nabavi SM; Shen AZ
Theranostics; 2019; 9(7):1923-1951. PubMed ID: 31037148
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.
Shou JW; Shaw PC
Cells; 2022 Feb; 11(5):. PubMed ID: 35269418
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.
Xu X; Yi H; Wu J; Kuang T; Zhang J; Li Q; Du H; Xu T; Jiang G; Fan G
Biomed Pharmacother; 2021 Jan; 133():110984. PubMed ID: 33186794
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential.
Huang DN; Wu FF; Zhang AH; Sun H; Wang XJ
Pharmacol Res; 2021 Jul; 169():105667. PubMed ID: 33989762
[TBL] [Abstract][Full Text] [Related]
5. Biological Activity of Berberine-A Summary Update.
Och A; Podgórski R; Nowak R
Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33198257
[TBL] [Abstract][Full Text] [Related]
6. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases.
Guo HH; Feng CL; Zhang WX; Luo ZG; Zhang HJ; Zhang TT; Ma C; Zhan Y; Li R; Wu S; Abliz Z; Li C; Li XL; Ma XL; Wang LL; Zheng WS; Han YX; Jiang JD
Nat Commun; 2019 Apr; 10(1):1981. PubMed ID: 31040273
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of berberine on various kidney diseases: Emphasis on the promising effects and the underlined molecular mechanisms.
Hassanein EHM; Ibrahim IM; Abd-Alhameed EK; Mohamed NM; Ross SA
Life Sci; 2022 Oct; 306():120697. PubMed ID: 35718235
[TBL] [Abstract][Full Text] [Related]
8. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
Zhu C; Li K; Peng XX; Yao TJ; Wang ZY; Hu P; Cai D; Liu HY
Front Immunol; 2022; 13():1083788. PubMed ID: 36561763
[TBL] [Abstract][Full Text] [Related]
9. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.
Zhu X; Bian H; Gao X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754444
[TBL] [Abstract][Full Text] [Related]
10. Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine.
Wang S; Xu Z; Cai B; Chen Q
Endocr Metab Immune Disord Drug Targets; 2021; 21(6):971-979. PubMed ID: 32914727
[TBL] [Abstract][Full Text] [Related]
11. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders.
Kong WJ; Vernieri C; Foiani M; Jiang JD
Pharmacol Ther; 2020 May; 209():107496. PubMed ID: 32001311
[TBL] [Abstract][Full Text] [Related]
12. Learning from berberine: Treating chronic diseases through multiple targets.
Yao J; Kong W; Jiang J
Sci China Life Sci; 2015 Sep; 58(9):854-9. PubMed ID: 24174332
[TBL] [Abstract][Full Text] [Related]
13. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
14. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
15. Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders.
Caliceti C; Franco P; Spinozzi S; Roda A; Cicero AF
Curr Med Chem; 2016; 23(14):1460-76. PubMed ID: 27063256
[TBL] [Abstract][Full Text] [Related]
16. Molecular updates on berberine in liver diseases: Bench to bedside.
Bansod S; Saifi MA; Godugu C
Phytother Res; 2021 Oct; 35(10):5459-5476. PubMed ID: 34056769
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of berberine against neurodegenerative diseases.
Jiang W; Li S; Li X
Sci China Life Sci; 2015 Jun; 58(6):564-9. PubMed ID: 25749423
[TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway.
Zhou J; Yu Y; Yang X; Wang Y; Song Y; Wang Q; Chen Z; Zong S; Fan M; Meng X; Xie C; Zhou F; Liu H; Wei F
Eur J Pharmacol; 2019 Jun; 852():179-188. PubMed ID: 30796904
[TBL] [Abstract][Full Text] [Related]
19. Promising Antioxidative Effect of Berberine in Cardiovascular Diseases.
An N; Zhang G; Li Y; Yuan C; Yang F; Zhang L; Gao Y; Xing Y
Front Pharmacol; 2022; 13():865353. PubMed ID: 35321323
[TBL] [Abstract][Full Text] [Related]
20. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
